Pharmaceutical formulations for preventing drug tolerance

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20040091534A1
SERIAL NO

10420944

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Isosorbide mononitrate formulations and methods of treatment are disclosed. The formulations and treatments provide for subtherapeutic levels of the mononitrate in a washout period to prevent nitrate tolerance.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CIRC PHARMA RESEARCH AND DEVELOPMENT LIMITED45 FITZWILLIAM SQUARE DUBLIN 2

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Foynes, Mary Margaret Athlone, IE 2 14
Geoghegan, Edward James Athlone, IE 2 14
Mulligan, Seamus Athlone, IE 47 969

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation